- Warfarin, oral, 5 mg daily adjusted to maintain INR between 2 and 3.
- Warfarin interactions:
A large number of medicines interact with warfarin leading to under- or over-anticoagulation, and careful evaluation of all new medicines, herbal and over-the counter products is critical. This includes (but is not an exhaustive list):
- Medicines altering platelet function e.g. NSAIDs, aspirin, clopidogrel, etc.
- Food or medicines altering vitamin K synthesis e.g. antibiotics.
- Medicines interfering with warfarin metabolism e.g. efavirenz, rifampicin, macrolide antibiotics, simvastatin, phenytoin, carbamazepine, etc.
- Grapefruit juice.
Unless INR is markedly out of range the modest adjustments recorded below should be followed:
Initiation
Day therapy | INR Value | Total daily dose |
Day 1 |
5 mg daily (2.5 mg daily for high sensitivity) |
|
2 to 3 days after initiation |
< 1.5 1.5 – 1.9 2.0 – 2.5 > 2.5 |
5–7.5 mg daily 2.5–5 mg daily 2.5 mg daily Hold warfarin and recheck INR next day |
2 to 3 days after last INR check |
< 1.5 1.5 – 1.9 2.0 – 3.0 > 3.0 |
7.5–10 mg daily 5–10 mg daily 2.5–5 mg daily Hold warfarin and recheck INR in1–2 days |
Check INR | |
Every 2–3 days |
Until INR within therapeutic range on 2 consecutive INR checks |
Then every week |
Until INR within therapeutic range on 2 consecutive INR checks |
Then every 2 weeks |
Until INR within therapeutic range on 2 consecutive INR checks |
Then every 4 weeks |
When dose is stable, check monthly |
Maintenance
Warfarin maintenance dosing protocol to maintain an INR 2-3:
INR<1.5 |
INR: 1.5-1.9 |
INR: 2.0-3.0 |
INR: 3.1-4.0 |
INR: 4.1-5 |
INR: 5.1-9.0 |
INR>9.0 |
Extra Dose. Increase weekly dose 10%. |
Increase weekly dose 5%. |
No change. |
Decrease weekly dose 5%. |
Withhold 1 dose. Decrease weekly dose 10%. |
*Withold 2 doses. Decrease weekly dose 20%. |
Admit. |
*History and examination to exclude bleeding. Admit persons with additional risks for bleeding.
Check INR | |
Every 3–5 days | If start/stop interacting medication, change in diet, change in activity level or other change that could affect INR. |
Every 1–2 weeks | If dose needed adjustment by 5–10%. |
Every 4 weeks | If maintained on same stable dose < 6 months. |
Every 6–8 weeks | If maintained on same stable dose ≥ 6 months. |